Compare BioNTech SE - ADR (BNTX) vs Kyndryl Holdings Inc (KD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNTech SE - ADR vs Kyndryl Holdings Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Kyndryl Holdings Inc trades at $13.26 (market cap $2.91B). The key difference: BioNTech SE - ADR is far larger — about 8× Kyndryl Holdings Inc's market cap, and BioNTech SE - ADR is trading nearer its 52-week high, Kyndryl Holdings Inc nearer its low. Which is the better fit depends on your goals.
| BNTX | KD | |
|---|---|---|
Market Cap | $23.31B | $2.91B |
Sector | Health | Technology |
52-Week High | $119.34 | $33.14 |
52-Week Low | $83.89 | $10.59 |
Enterprise Value | $6.60B | $5.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BioNTech SE - ADR
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →About Kyndryl Holdings Inc
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →
